Response to thyrotrophin-releasing hormone

The influence of plasma on basal and ACTH-stimulated in vitro adrenocortical steroidogenesis.

The Journal of endocrinology·1999

Prolonged large bowel transit increases serum deoxycholic acid: a risk factor for octreotide induced gallstones.

Gut·1999

Carcinoid tumours presenting as breast cancer: the utility of radionuclide imaging with 123I-MIBG and 111In-DTPA pentetreotide.

Clinical endocrinology·1999

A critical analysis of the value of simultaneous inferior petrosal sinus sampling in Cushing's disease and the occult ectopic adrenocorticotropin syndrome.

The Journal of clinical endocrinology and metabolism·1999

Computed tomography appearance of the thymus and anterior mediastinum in active Cushing's syndrome.

The Journal of clinical endocrinology and metabolism·1999

Serum cytokines in thyrotoxicosis.

The Journal of clinical endocrinology and metabolism·1999

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Immune Circuit Rewiring by HDAC Inhibition Enables Response to Dual Checkpoint Blockade in Metastatic Breast Cancer.

Cancer research·2026

Synchronous Papillary Thyroid Carcinoma and an Angiomatoid Fibrous Histiocytoma: A Rare, Interesting Case Report.

Cureus·2026

Hyalinizing Trabecular Tumor of the Thyroid Gland: A Diagnostic and Surgical Challenge.

Cureus·2026

Neural regulation of immune evasion in breast cancer: a multiscale neuro-immune framework.

Frontiers in immunology·2026

Beyond exhaustion: T cell fitness for next generation of immunotherapy for hematological cancer.

Frontiers in immunology·2026

Latent effector T cells mediate immunotherapy responses in the bone marrow microenvironment.

Cancer cell·2026

Related Experiment Videos

Response to thyrotrophin-releasing hormone

Related Concept Videos

The influence of plasma on basal and ACTH-stimulated in vitro adrenocortical steroidogenesis.

Prolonged large bowel transit increases serum deoxycholic acid: a risk factor for octreotide induced gallstones.

Carcinoid tumours presenting as breast cancer: the utility of radionuclide imaging with 123I-MIBG and 111In-DTPA pentetreotide.

A critical analysis of the value of simultaneous inferior petrosal sinus sampling in Cushing's disease and the occult ectopic adrenocorticotropin syndrome.

Computed tomography appearance of the thymus and anterior mediastinum in active Cushing's syndrome.

Serum cytokines in thyrotoxicosis.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Immune Circuit Rewiring by HDAC Inhibition Enables Response to Dual Checkpoint Blockade in Metastatic Breast Cancer.

Synchronous Papillary Thyroid Carcinoma and an Angiomatoid Fibrous Histiocytoma: A Rare, Interesting Case Report.

Hyalinizing Trabecular Tumor of the Thyroid Gland: A Diagnostic and Surgical Challenge.

Neural regulation of immune evasion in breast cancer: a multiscale neuro-immune framework.

Beyond exhaustion: T cell fitness for next generation of immunotherapy for hematological cancer.

Latent effector T cells mediate immunotherapy responses in the bone marrow microenvironment.

Related Experiment Videos

Response to thyrotrophin-releasing hormone

Related Concept Videos

Related Articles